{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T07:41:10Z","timestamp":1781595670464,"version":"3.54.5"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>Type 2 diabetes mellitus (T2DM) is associated with a prothrombotic state; however, its hemostatic profile in conflict-affected populations remains poorly characterized. This study aimed to evaluate coagulation parameters and platelet indices among Yemeni adults with T2DM and to correlate these markers with glycemic control. A case-control study was conducted on 140 T2DM patients and 100 age- and sex-matched non-diabetic controls in Aden, Yemen. Prothrombin time (PT), activated partial thromboplastin time (APTT), mean platelet volume (MPV), and platelet distribution width (PDW) were measured using standardized analyzers (STA-R Evolution and Sysmex XN-550). Glycemic control was assessed via HbA1c. Poor glycemic control (HbA1c\u2009\u2265\u20097%) was observed in 86% of patients. T2DM patients exhibited a distinct coagulation profile: prolonged PT (13.4\u2009\u00b1\u20091.8 vs. 12.1\u2009\u00b1\u20091.2 sec, p\u2009&lt;\u20090.01) and shortened APTT (32.5\u2009\u00b1\u20094.1 vs. 35.2\u2009\u00b1\u20093.5 sec, p\u2009=\u20090.02) compared to controls. Platelet indices were significantly elevated: MPV (10.2\u2009\u00b1\u20091.5 vs. 8.7\u2009\u00b1\u20091.1 fL, p\u2009&lt;\u20090.001) and PDW (16.8\u2009\u00b1\u20092.1 vs. 15.2\u2009\u00b1\u20091.8%, p\u2009=\u20090.01). A moderate positive correlation was observed between HbA1c and MPV (r\u2009=\u20090.52, p\u2009&lt;\u20090.001). Yemeni T2DM patients display altered coagulation parameters\u2014prolonged PT alongside shortened APTT\u2014combined with significant platelet activation. These findings highlight the importance of hemostatic assessment in diabetic care in this population. Routine screening of PT, APTT, and platelet indices may help stratify thrombotic risk and guide clinical management.<\/jats:p>","DOI":"10.1371\/journal.pgph.0005173","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:22:16Z","timestamp":1769019736000},"page":"e0005173","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Altered coagulation and platelet indices in Yemeni patients with type 2 diabetes mellitus: A conflict-affected population"],"prefix":"10.1371","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2266-1569","authenticated-orcid":true,"given":"Naif Taleb","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radfan Saleh","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour Abdelnabi","family":"H. Mehdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5504-1920","authenticated-orcid":true,"given":"Gamila Saleh","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"pgph.0005173.ref001","volume-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2021","edition":"10"},{"issue":"2","key":"pgph.0005173.ref002","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2796.2007.01824.x","article-title":"Diabetes mellitus as a prothrombotic condition","volume":"262","author":"PJ Grant","year":"2007","journal-title":"J Intern Med"},{"issue":"4","key":"pgph.0005173.ref003","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2337\/dc08-1865","article-title":"Factors contributing to increased platelet reactivity in people with diabetes","volume":"32","author":"DJ Schneider","year":"2009","journal-title":"Diabetes Care"},{"issue":"3","key":"pgph.0005173.ref004","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.thromres.2011.11.052","article-title":"Diabetes mellitus and thrombosis","volume":"129","author":"N Vazzana","year":"2012","journal-title":"Thromb Res"},{"issue":"1","key":"pgph.0005173.ref005","article-title":"Platelet indices in T2DM","volume":"22","author":"F Jabeen","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"1","key":"pgph.0005173.ref006","first-page":"55","article-title":"Coagulation and fibrinolysis in diabetes","volume":"15","author":"SH Alzahrani","year":"2018","journal-title":"Diab Vasc Dis Res"},{"issue":"1","key":"pgph.0005173.ref007","first-page":"20","article-title":"Relationship between coagulation markers and microvascular complications in type 2 diabetes","volume":"32","author":"LM El-Wakeel","year":"2020","journal-title":"Egypt J Intern Med"},{"issue":"5","key":"pgph.0005173.ref008","first-page":"879","article-title":"Platelet activation in metabolic syndrome and diabetes mellitus","volume":"30","author":"G Davi","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"pgph.0005173.ref009","first-page":"110215","article-title":"MPV as thrombotic predictor","volume":"195","author":"A Al-Haddad","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"pgph.0005173.ref010","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.4081\/itjm.2025.1875","article-title":"Role of platelet indices and vitamin D in forecasting deterioration of glycemic control and vascular complications in type 2 diabetes","volume":"19","author":"M Ahmed Obaid Al Ali","year":"2025","journal-title":"Ital J Med"},{"issue":"4","key":"pgph.0005173.ref011","first-page":"336","article-title":"The relationship between glycemic control and platelet activity in type 2 diabetes mellitus","volume":"101","author":"R Demirtunc","year":"2009","journal-title":"J Natl Med Assoc"},{"issue":"2","key":"pgph.0005173.ref012","first-page":"87","article-title":"Hemostatic profile in type 2 diabetes mellitus patients in Lagos, Nigeria","volume":"9","author":"AO Ogbera","year":"2006","journal-title":"Niger J Clin Pract"},{"issue":"9","key":"pgph.0005173.ref013","first-page":"629","article-title":"Prevalence of known diabetes mellitus in Aden Governorate, Yemen","volume":"25","author":"AA Gunaid","year":"2019","journal-title":"East Mediterr Health J"},{"issue":"3","key":"pgph.0005173.ref014","first-page":"198","article-title":"Metformin and vitamin K deficiency","volume":"42","author":"O Harzallah","year":"2016","journal-title":"Diabetes Metab"},{"issue":"3","key":"pgph.0005173.ref015","first-page":"198","article-title":"Metformin and vitamin K deficiency: an underestimated side effect","volume":"42","author":"O Harzallah","year":"2016","journal-title":"Diabetes Metab"},{"issue":"1","key":"pgph.0005173.ref016","first-page":"58","article-title":"The state of the health system in Yemen: a qualitative study","volume":"16","author":"KA Fenton","year":"2022","journal-title":"Confl Health"},{"issue":"8","key":"pgph.0005173.ref017","first-page":"396","article-title":"Hemostatic and inflammatory markers in Saudi patients with type 2 diabetes mellitus","volume":"30","author":"SM Saadeddin","year":"2019","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"8","key":"pgph.0005173.ref018","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3109\/07853890.2011.653391","article-title":"Are platelet volume indices of clinical use? A multidisciplinary review","volume":"44","author":"A Leader","year":"2012","journal-title":"Ann Med"},{"issue":"2","key":"pgph.0005173.ref019","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1179\/102453311X12940641877849","article-title":"Proposal of a score combining red blood cell indices for early differentiation of beta-thalassemia minor from iron deficiency anemia","volume":"16","author":"A Janel","year":"2011","journal-title":"Hematology"},{"key":"pgph.0005173.ref020","first-page":"45","article-title":"The role of mean platelet volume and platelet distribution width in the prognosis of intermediate-risk pulmonary embolism","volume":"45","author":"EA El-Gendy","year":"2020","journal-title":"Egypt J Haematol"},{"issue":"3","key":"pgph.0005173.ref021","first-page":"111","article-title":"Hemostatic changes and protein C deficiency in diabetic nephropathy","volume":"40","author":"M Shalaby","year":"2015","journal-title":"Egypt J Haematol"},{"issue":"6","key":"pgph.0005173.ref022","first-page":"574","article-title":"Coagulation parameters in patients with type 2 diabetes mellitus with and without diabetic nephropathy","volume":"22","author":"G Fidan-Yaylali","year":"2016","journal-title":"Clin Appl Thromb\/Hemost"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0005173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:22:22Z","timestamp":1769019742000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0005173"}},"subtitle":[],"editor":[{"given":"Paolo Ivo","family":"Cavoretto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0005173","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]}}}